BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu P, Gao M, Yung KKL. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis. ACS Chem Neurosci 2020;11:395-405. [PMID: 31876406 DOI: 10.1021/acschemneuro.9b00607] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Procházková N, Falony G, Dragsted LO, Licht TR, Raes J, Roager HM. Advancing human gut microbiota research by considering gut transit time. Gut 2022:gutjnl-2022-328166. [PMID: 36171079 DOI: 10.1136/gutjnl-2022-328166] [Reference Citation Analysis]
2 Wang X, Jiang D, Li T, Zhang X, Wang R, Gao S, Yang F, Wang Y, Tian Q, Xie C, Liang J. Association between microbiological risk factors and neurodegenerative disorders: An umbrella review of systematic reviews and meta-analyses. Front Psychiatry 2022;13:991085. [DOI: 10.3389/fpsyt.2022.991085] [Reference Citation Analysis]
3 Cui G, Li S, Ye H, Yang Y, Huang Q, Chu Y, Shi Z, Zhang X. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study. Front Immunol 2022;13:956005. [DOI: 10.3389/fimmu.2022.956005] [Reference Citation Analysis]
4 Li H, Wen Z. Effects of ulcerative colitis and Crohn’s disease on neurodegenerative diseases: A Mendelian randomization study. Front Genet 2022;13:846005. [DOI: 10.3389/fgene.2022.846005] [Reference Citation Analysis]
5 Nakase T, Tatewaki Y, Thyreau B, Mutoh T, Tomita N, Yamamoto S, Takano Y, Muranaka M, Taki Y. Impact of constipation on progression of Alzheimer's disease: A retrospective study. CNS Neurosci Ther 2022. [PMID: 35934956 DOI: 10.1111/cns.13940] [Reference Citation Analysis]
6 Du H, Wang D, Zhang X. Inflammatory bowel disease: A potential pathogenic factor of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110610. [PMID: 35908596 DOI: 10.1016/j.pnpbp.2022.110610] [Reference Citation Analysis]
7 Sand JR, Troelsen FS, Horváth-Puhó E, Henderson VW, Sørensen HT, Erichsen R. Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study. Aliment Pharmacol Ther 2022. [PMID: 35781292 DOI: 10.1111/apt.17119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li Z, Zhou J, Liang H, Ye L, Lan L, Lu F, Wang Q, Lei T, Yang X, Cui P, Huang J. Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases. Front Neurosci 2022;16:879318. [DOI: 10.3389/fnins.2022.879318] [Reference Citation Analysis]
9 Xie A, Ensink E, Li P, Gordevičius J, Marshall LL, George S, Pospisilik JA, Aho VTE, Houser MC, Pereira PAB, Rudi K, Paulin L, Tansey MG, Auvinen P, Brundin P, Brundin L, Labrie V, Scheperjans F. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms. Mov Disord 2022. [PMID: 35723531 DOI: 10.1002/mds.29128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pap D, Veres-Székely A, Szebeni B, Vannay Á. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases. Int J Mol Sci 2022;23:6626. [PMID: 35743072 DOI: 10.3390/ijms23126626] [Reference Citation Analysis]
11 Zheng H, Qian X, Tian W, Cao L. Exploration of the Common Gene Characteristics and Molecular Mechanism of Parkinson's Disease and Crohn's Disease from Transcriptome Data. Brain Sci 2022;12:774. [PMID: 35741659 DOI: 10.3390/brainsci12060774] [Reference Citation Analysis]
12 Xia Y, Prokop S, Bell BM, Gorion KM, Croft CL, Nasif L, Xu G, Riffe CJ, Manaois AN, Strang KH, Quintin SS, Paterno G, Tansey MG, Borchelt DR, Golde TE, Giasson BI. Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice. Commun Biol 2022;5:446. [PMID: 35550593 DOI: 10.1038/s42003-022-03373-1] [Reference Citation Analysis]
13 Shukla R, Pahal S, Gupta A, Choudhary P, Misra K, Singh S. Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer’s and Parkinson’s diseases as druggable targets through Withania somnifera bioactives: an in silico study. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2068072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lu S, Jiang HY, Shi YD. Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis. Acta Neurol Scand 2022;145:442-8. [PMID: 34908158 DOI: 10.1111/ane.13570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liebert A, Bicknell B, Laakso EL, Jalilitabaei P, Tilley S, Kiat H, Mitrofanis J. Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19. Photobiomodul Photomed Laser Surg 2022;40:112-22. [PMID: 34919459 DOI: 10.1089/photob.2021.0056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Daniel H. Diet and Gut Microbiome and the “Chicken or Egg” Problem. Front Nutr 2022;8:828630. [DOI: 10.3389/fnut.2021.828630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang F, Fei M, Hu W, Wang X, Liu S, Zeng Y, Zhang J, Lv Y, Niu J, Meng X, Cai P, Li Y, Gang B, You Y, Lv Y, Ji Y. Prevalence of Constipation in Elderly and Its Association With Dementia and Mild Cognitive Impairment: A Cross-Sectional Study. Front Neurosci 2022;15:821654. [DOI: 10.3389/fnins.2021.821654] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sun Q, Du M, Kang Y, Zhu MJ. Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 34991393 DOI: 10.1080/10408398.2021.2015680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bicknell B, Liebert A, McLachlan CS, Kiat H. Microbiome Changes in Humans with Parkinson's Disease after Photobiomodulation Therapy: A Retrospective Study. J Pers Med 2022;12:49. [PMID: 35055364 DOI: 10.3390/jpm12010049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wang C, Yin Y, Wang L, Guo X, Liu L, Qi X. Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis. Postgrad Med J 2021:postgradmedj-2021-141127. [PMID: 34930813 DOI: 10.1136/postgradmedj-2021-141127] [Reference Citation Analysis]
21 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M. Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications. Transl Neurodegener 2021;10:49. [PMID: 34876226 DOI: 10.1186/s40035-021-00273-y] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 Berlamont H, Bruggeman A, Bauwens E, Vandendriessche C, Clarebout E, Xie J, De Bruyckere S, Van Imschoot G, Van Wonterghem E, Ducatelle R, Santens P, Smet A, Haesebrouck F, Vandenbroucke RE. Gastric Helicobacter suis Infection Partially Protects against Neurotoxicity in A 6-OHDA Parkinson's Disease Mouse Model. Int J Mol Sci 2021;22:11328. [PMID: 34768765 DOI: 10.3390/ijms222111328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang X, Svn Z, Liv M, Yang Y, Zeng R, Huang Q, Sun Q. Association Between Irritable Bowel Syndrome and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:720958. [PMID: 34630293 DOI: 10.3389/fneur.2021.720958] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
25 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021;132:325-44. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Kim GH, Lee YC, Kim TJ, Kim ER, Hong SN, Chang DK, Kim YH. Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study. J Crohns Colitis 2021:jjab162. [PMID: 34499125 DOI: 10.1093/ecco-jcc/jjab162] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
27 Bisogno T, Lauritano A, Piscitelli F. The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota. Life (Basel) 2021;11:934. [PMID: 34575083 DOI: 10.3390/life11090934] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Shi M, Li C, Tian X, Chu F, Zhu J. Can Control Infections Slow Down the Progression of Alzheimer's Disease? Talking About the Role of Infections in Alzheimer's Disease. Front Aging Neurosci 2021;13:685863. [PMID: 34366826 DOI: 10.3389/fnagi.2021.685863] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
29 Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders: A systematic review and meta-analysis. Life Sci 2021;281:119767. [PMID: 34216625 DOI: 10.1016/j.lfs.2021.119767] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Singh A, Dawson TM, Kulkarni S. Neurodegenerative disorders and gut-brain interactions. J Clin Invest 2021;131:143775. [PMID: 34196307 DOI: 10.1172/JCI143775] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
31 Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12741. [PMID: 32918343 DOI: 10.1111/hel.12741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
32 Borghammer P. The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline. J Parkinsons Dis 2021;11:455-74. [PMID: 33682732 DOI: 10.3233/JPD-202481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
33 Li XQ, Feng X, Jiang Z. Comment on "Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis". ACS Chem Neurosci 2021;12:810. [PMID: 33503364 DOI: 10.1021/acschemneuro.0c00703] [Reference Citation Analysis]
34 Santiago JA, Potashkin JA. The Impact of Disease Comorbidities in Alzheimer's Disease. Front Aging Neurosci 2021;13:631770. [PMID: 33643025 DOI: 10.3389/fnagi.2021.631770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
35 Hanscom M, Loane DJ, Aubretch T, Leser J, Molesworth K, Hedgekar N, Ritzel RM, Abulwerdi G, Shea-Donohue T, Faden AI. Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits. J Neuroinflammation 2021;18:24. [PMID: 33461596 DOI: 10.1186/s12974-020-02067-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
36 Madison AA, Kiecolt-Glaser JK. The gut microbiota and nervous system: Age-defined and age-defying. Semin Cell Dev Biol 2021;116:98-107. [PMID: 33422403 DOI: 10.1016/j.semcdb.2020.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira e Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol 2020; 26(28): 4076-4093 [PMID: 32821071 DOI: 10.3748/wjg.v26.i28.4076] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
38 Lim KH, Joo JY. Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer's Disease. Int J Mol Sci 2020;21:E3398. [PMID: 32403399 DOI: 10.3390/ijms21093398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
39 Fu P, Bai L, Cai Z, Li R, Yung KKL. Fine particulate matter aggravates intestinal and brain injury and affects bacterial community structure of intestine and feces in Alzheimer's disease transgenic mice. Ecotoxicol Environ Saf 2020;192:110325. [PMID: 32078839 DOI: 10.1016/j.ecoenv.2020.110325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]